CASTELLI, SILVIA

CASTELLI, SILVIA  

Dipartimento di Biologia  

Mostra records
Risultati 1 - 20 di 29 (tempo di esecuzione: 0.035 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2021 @IT2020: An innovative algorithm for allergen immunotherapy prescription in seasonal allergic rhinitis Arasi, S; Castelli, S; Di Fraia, M; Villalta, D; Tripodi, S; Perna, S; Dramburg, S; Brighetti, M; Conte, M; Martelli, P; Sfika, I; Travaglini, A; Verardo, P; Villella, V; Matricardi, P Articolo su rivista
1-feb-2013 A natural anticancer agent thaspine targets human topoisomerase IB Castelli, S; Katkar, P; Vassallo, O; Falconi, M; Linder, S; Desideri, A Articolo su rivista
1-gen-2019 A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: a validation study Di Fraia, M; Arasi, S; Castelli, S; Hofmaier, S; Potapova, E; Villalta, D; Tripodi, S; Sfika, I; Zicari, A; Villella, V; Perna, S; Travaglini, A; Verardo, P; Matricardi, P Articolo su rivista
1-gen-2019 A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: A validation study Di Fraia, M; Arasi, S; Castelli, S; Dramburg, S; Potapova, E; Villalta, D; Tripodi, S; Sfika, I; Zicari, Am; Villella, V; Perna, S; Travaglini, A; Verardo, Pl; Matricardi, Pm Articolo su rivista
1-gen-2003 Active site copper and zinc ions modulate the quaternary structure of prokaryotic Cu,Zn superoxide dismutase Cioni, P; Apesce, B; MOROZZO DELLA ROCCA, B; Castelli, S; Falconi, M; Parrilli, L; Bolognesi, M; Strambini, G; Desideri, A Articolo su rivista
1-gen-2005 Catterizzazione della dna topoisomerasi I umana e della sua interazione con il farmaco antitumorale camptotecina - Tesi di dottorato
1-gen-2009 Conjugated eicosapentaenoic acid inhibits human topoisomerase IB with a mechanism different from camptothecin. Castelli, S; Campagna, A; Vassallo, O; Tesauro, C; Fiorani, P; Tagliatesta, P; Oteri, F; Falconi, M; Majumder, H; Desideri, A Articolo su rivista
15-mag-2017 Efficacy of a Binuclear Cyclopalladated Compound Therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis and its inhibitory effect on Topoisomerase 1B Velásquez, A; Ribeiro, W; Venn, V; Castelli, S; Santoro, M; de Assis, R; de Souza, R; Ribeiro, A; Passalaqua, T; da Rosa, J; Baviera, A; Mauro, A; Desideri, A; Almeida Amaral, E; Graminha, M Articolo su rivista
1-ott-2011 Evidences of a natively unfolded state for the human topoisomerase IB N-terminal domain Vassallo, O; Castelli, S; D'Annessa, I; MOROZZO DELLA ROCCA, B; Stella, L; Knudsen, B; Desideri, A Articolo su rivista
1-gen-2016 Human topoisomerase IB is a target of a thiosemicarbazone copper(II) complex Vutey, V; Castelli, S; D'Annessa, I; Samia, L; Souza Fagundes, E; Beraldo, H; Desideri, A Articolo su rivista
29-lug-2015 Importance of a stable topoisomerase IB clamping for an efficient DNA processing: Effect of the Lys369Glu mutation Vieira, S; Castelli, S; Desideri, A Articolo su rivista
1-gen-2014 In vitro analysis of pyrogenicity and cytotoxicity profiles of flex sensors to be used to sense human joint postures Saggio, G; Bianchi, L; Castelli, S; Santucci, Mb; Fraziano, M; Desideri, A Articolo su rivista
1-gen-2016 Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(ii)-based compounds with antitumoral activity de Camargo, M; da Silva, M; Correa, R; Vieira, S; Castelli, S; D'Anessa, I; De Grandis, R; Varanda, E; Deflon, V; Desideri, A; Batista, A Articolo su rivista
1-nov-2012 Interaction between natural compounds and human topoisomerase I Castelli, S; Coletta, A; D'Annessa, I; Fiorani, P; Tesauro, C; Desideri, A Articolo su rivista
1-gen-2021 Lipid catabolism and ROS in cancer: a bidirectional liaison Castelli, S; De Falco, P; Ciccarone, F; Desideri, E; Ciriolo, Mr Articolo su rivista
18-apr-2016 Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex Samia, Lbp; Parrilha, Gl; Da Silva, Jg; Ramos, Jp; Souza-Fagundes, Em; Castelli, S; Vutey, V; Desideri, A; Beraldo, H Articolo su rivista
1-gen-2005 New hints on the pH-driven tautomeric equilibria of the topotecan anticancer drug in aqueous solutions from an integrated spectroscopic and quantum-mechanical approach Sanna, N; Chillemi, G; Grandi, A; Castelli, S; Desideri, A; Barone, V Articolo su rivista
4-set-2019 Non-mutagenic Ru(ii) complexes: Cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding Da Silva, Mm; De Camargo, Ms; Correa, Rs; Castelli, S; De Grandis, Ra; Takarada, Je; Varanda, Ea; Castellano, Ee; Deflon, Vm; Cominetti, Mr; Desideri, A; Batista, Aa Articolo su rivista
1-gen-2015 Oxidovanadium(IV) complexes with chrysin and silibinin: Anticancer activity and mechanisms of action in a human colon adenocarcinoma model Leon, I; Cadavid Vargas, J; Tiscornia, I; Porro, V; Castelli, S; Katkar, P; Desideri, A; Bollati Fogolin, M; Etcheverry, S Articolo su rivista
30-ott-2019 Palladium(ii) complexes with thiosemicarbazones derived from pyrene as topoisomerase IB inhibitors Oliveira, Cg; Romero-Canelon, I; Silva, Mm; Coverdale, Jpc; Maia, Pis; Batista, Aa; Castelli, S; Desideri, A; Sadler, Pj; Deflon, Vm Articolo su rivista